SurgePays (SURG) EBIT (2010 - 2026)

SurgePays has disclosed EBIT across 17 years of filings, most recently posting -$11.2 million for Q1 2026.

• In Q1 2026, EBIT fell 47.75% year-over-year to -$11.2 million; the TTM figure through Mar 2026 stood at -$37.8 million (up 28.49% YoY), while the FY2025 annual figure was -$34.1 million, up 21.46% from the prior year.
• EBIT climbed to -$11.2 million in Q1 2026, from -$12.8 million in the prior quarter.
• Over the last five years, EBIT for SURG reached as high as $7.1 million in Q3 2023 and fell as low as -$20.1 million in Q4 2024.
• The 5-year median for EBIT is -$1.1 million (2022), against an average of -$4.1 million.
• Annual changes were most pronounced in 2022 — EBIT soared 4001.1% — and 2024, when it plunged 2415.62%.
• A 5-year view of EBIT shows it stood at $3.5 million in 2022, then sank by 75.56% to $866249.0 in 2023, then sank by 2415.62% to -$20.1 million in 2024, then jumped by 36.21% to -$12.8 million in 2025, then gained by 12.48% to -$11.2 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$11.2 million, -$12.8 million, and -$7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.